CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
-7.62%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$897M
AUM Growth
-$248M
(-22%)
Cap. Flow
-$48M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
70.4%
Holding
43
New
2
Increased
7
Reduced
12
Closed
5
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$20.7M |
| 2 |
Structure Therapeutics
GPCR
|
$12.9M |
| 3 |
Pacific Biosciences
PACB
|
$8.65M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$7.88M |
| 5 |
Relay Therapeutics
RLAY
|
$7.78M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$31.2M |
| 2 |
Illumina
ILMN
|
$17.8M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$14.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$12.5M |
| 5 |
Twist Bioscience
TWST
|
$9.21M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MaxCyte
MXCT
$150M
| $5.9M | 0.65% |
1,890,000
-2,825,000
| -60% | -$8.81M |
|
27
Fate Therapeutics
FATE
$116M
| $4.35M | 0.48% |
2,050,000
| – | – |
|
28
Prime Medicine
PRME
$663M
| $3.5M | 0.39% |
367,175
| – | – |
|
29
Standard BioTools
LAB
$497M
| $3.48M | 0.39% |
1,200,000
| – | – |
|
|
30
Illumina
ILMN
$15.7B
| $3.43M | 0.38% |
25,700
-133,640
| -84% | -$17.8M |
|
31
Sana Biotechnology
SANA
$752M
| $2.9M | 0.32% |
750,000
| – | – |
|
32
Monte Rosa Therapeutics
GLUE
$305M
| $2.45M | 0.27% |
510,882
| – | – |
|
33
Absci
ABSI
$368M
| $1.28M | 0.14% |
973,260
-395,000
| -29% | -$521K |
|
|
EXAI
34
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $967K | 0.11% |
213,900
| – | – |
|
35
Codexis
CDXS
$218M
| $567K | 0.06% |
+300,000
| New | +$567K |
|
|
OMIC
36
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $504K | 0.06% |
44,130
-727
| -2% | -$8.31K |
|
|
LIAN
37
DELISTED
LianBio American Depositary Shares
LIAN
| $308K | 0.03% |
206,415
| – | – |
|
|
KRON
38
DELISTED
Kronos Bio
KRON
| $161K | 0.02% |
123,839
| – | – |
|
|
SAGE
39
DELISTED
Sage Therapeutics
SAGE
| – | – |
-90,000
| Closed | -$4.23M |
|
40
Scilex Holding
SCLX
$159M
| – | – |
-672
| Closed | -$131K |
|
|
41
Twist Bioscience
TWST
$1.55B
| – | – |
-450,000
| Closed | -$9.21M |
|
|
CTLT
42
DELISTED
CATALENT, INC.
CTLT
| – | – |
-720,000
| Closed | -$31.2M |
|
43
Incyte
INCY
$16.9B
| – | – |
-77,500
| Closed | -$4.82M |
|